-+ 0.00%
-+ 0.00%
-+ 0.00%

Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report

Benzinga·05/14/2024 20:26:19
Listen to the news

-SEC Filing